These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 1901437)

  • 1. Effects of time required for reperfusion (thrombolysis or angioplasty, or both) and location of acute myocardial infarction on left ventricular functional reserve capacity several months later.
    Little T; Crenshaw M; Liberman HA; Battey LL; Warner R; Churchwell AL; Eisner RL; Morris DC; Patterson RE
    Am J Cardiol; 1991 Apr; 67(9):797-805. PubMed ID: 1901437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variables predictive of good functional outcome following thrombolytic therapy in the Thrombolysis in Myocardial Infarction phase II (TIMI II) pilot study.
    Rogers WJ; Bourge RC; Papapietro SE; Wackers FJ; Zaret BL; Forman S; Dodge HT; Robertson TL; Passamani ER; Braunwald E
    Am J Cardiol; 1989 Mar; 63(9):503-12. PubMed ID: 2521976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of thrombolytic regimen, early catheterization, and predischarge angiographic variables on six-week left ventricular function. The TAMI Investigators. Thrombolysis and Angioplasty in Acute Myocardial Infarction.
    Ward SR; Sutton JM; Pieper KS; Schwaiger M; Califf RM; Topol EJ
    Am J Cardiol; 1997 Mar; 79(5):539-44. PubMed ID: 9068505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Importance of early and complete reperfusion to achieve myocardial salvage after thrombolysis in acute myocardial infarction.
    Clemmensen P; Ohman EM; Sevilla DC; Wagner NB; Quigley PS; Grande P; Wagner GS
    Am J Cardiol; 1992 Dec; 70(18):1391-6. PubMed ID: 1442606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized trial of late reperfusion therapy for acute myocardial infarction. Thrombolysis and Angioplasty in Myocardial Infarction-6 Study Group.
    Topol EJ; Califf RM; Vandormael M; Grines CL; George BS; Sanz ML; Wall T; O'Brien M; Schwaiger M; Aguirre FV
    Circulation; 1992 Jun; 85(6):2090-9. PubMed ID: 1591828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anistreplase versus alteplase in acute myocardial infarction: comparative effects on left ventricular function, morbidity and 1-day coronary artery patency. The TEAM-3 Investigators.
    Anderson JL; Becker LC; Sorensen SG; Karagounis LA; Browne KF; Shah PK; Morris DC; Fintel DJ; Mueller HS; Ross AM
    J Am Coll Cardiol; 1992 Oct; 20(4):753-66. PubMed ID: 1527286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized trial comparing primary angioplasty with a strategy of short-acting thrombolysis and immediate planned rescue angioplasty in acute myocardial infarction: the PACT trial. PACT investigators. Plasminogen-activator Angioplasty Compatibility Trial.
    Ross AM; Coyne KS; Reiner JS; Greenhouse SW; Fink C; Frey A; Moreyra E; Traboulsi M; Racine N; Riba AL; Thompson MA; Rohrbeck S; Lundergan CF
    J Am Coll Cardiol; 1999 Dec; 34(7):1954-62. PubMed ID: 10588209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for the delayed effect in human ischemic preconditioning: prospective multicenter study for preconditioning in acute myocardial infarction.
    Noda T; Minatoguchi S; Fujii K; Hori M; Ito T; Kanmatsuse K; Matsuzaki M; Miura T; Nonogi H; Tada M; Tanaka M; Fujiwara H
    J Am Coll Cardiol; 1999 Dec; 34(7):1966-74. PubMed ID: 10588211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relation of left ventricular volume and function over one year after acute myocardial infarction to infarct size determined by technetium-99m sestamibi.
    Christian TF; Behrenbeck T; Gersh BJ; Gibbons RJ
    Am J Cardiol; 1991 Jul; 68(1):21-6. PubMed ID: 1829319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Graded exercise testing following thrombolytic therapy for acute myocardial infarction: the importance of timing and infarct location. TPAT Study Group.
    Morgan CD; Gent M; Daly PA; Baigrie RS; Haq A; Roberts RS; Armstrong PW
    Can J Cardiol; 1994 Nov; 10(9):897-904. PubMed ID: 7954025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of a coronary artery with thrombolysis in myocardial infarction grade 2 flow "patency" (outcome in the thrombolysis and angioplasty in myocardial infarction trials). Thrombolysis and Angioplasty in Myocardial Infarction Study Group.
    Lincoff AM; Topol EJ; Califf RM; Sigmon KN; Lee KL; Ohman EM; Rosenschein U; Ellis SG
    Am J Cardiol; 1995 May; 75(14):871-6. PubMed ID: 7732992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of immediate invasive, delayed invasive, and conservative strategies after tissue-type plasminogen activator. Results of the Thrombolysis in Myocardial Infarction (TIMI) Phase II-A trial.
    Rogers WJ; Baim DS; Gore JM; Brown BG; Roberts R; Williams DO; Chesebro JH; Babb JD; Sheehan FH; Wackers FJ
    Circulation; 1990 May; 81(5):1457-76. PubMed ID: 2110033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue-type plasminogen activator therapy versus primary coronary angioplasty: impact on myocardial tissue perfusion and regional function 1 month after uncomplicated myocardial infarction.
    Agati L; Voci P; Hickle P; Vizza DC; Autore C; Fedele F; Feinstein SB; Dagianti A
    J Am Coll Cardiol; 1998 Feb; 31(2):338-43. PubMed ID: 9462577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of successful angioplasty following thrombolysis on infarct size and left ventricular function.
    Hirayama A; Nanto S; Asada S; Adachi T; Mishima M; Matsumura Y; Naito J; Nishida K; Naka M; Inoue M
    Int J Cardiol; 1994 Dec; 47(1 Suppl):S39-47. PubMed ID: 7737751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coronary patency, infarct size and left ventricular function after thrombolytic therapy for acute myocardial infarction: results from the tissue plasminogen activator: Toronto (TPAT) placebo-controlled trial. TPAT Study Group.
    Morgan CD; Roberts RS; Haq A; Baigrie RS; Daly PA; Gent M; Armstrong PW
    J Am Coll Cardiol; 1991 Jun; 17(7):1451-7. PubMed ID: 1903404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stress radionuclide studies after acute myocardial infarction: changes with revascularization.
    Coma-Canella I; del Val Gómez M; Salazar L; Gallardo F
    J Nucl Cardiol; 1996; 3(5):403-9. PubMed ID: 8902672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized controlled trial of late in-hospital angiography and angioplasty versus conservative management after treatment with recombinant tissue-type plasminogen activator in acute myocardial infarction.
    Barbash GI; Roth A; Hod H; Modan M; Miller HI; Rath S; Zahav YH; Keren G; Motro M; Shachar A
    Am J Cardiol; 1990 Sep; 66(5):538-45. PubMed ID: 2118299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Late outcome after percutaneous transluminal coronary angioplasty during acute myocardial infarction.
    O'Murchu B; Gersh BJ; Reeder GS; Bailey KR; Holmes DR
    Am J Cardiol; 1993 Sep; 72(9):634-9. PubMed ID: 8249836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Efficacy of intracoronary thrombolysis versus percutaneous transluminal coronary angioplasty for treating acute myocardial infarction].
    Nakamura M; Yamaguchi T; Isshiki T; Nagahara T; Itaoka Y; Saeki F
    J Cardiol; 1992; 22(4):607-16. PubMed ID: 1343626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Case report. Thrombolytic therapy 17 hours after acute myocardial infarct: assessing myocardial viability with 201 thallium imaging].
    Lund GK; Koschyk DH; Nienaber CA
    Herz; 1994 Feb; 19(1):65-8. PubMed ID: 8150415
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.